Characterization of sociodemographic and clinicopathological features in brazilian patients with vulvar squamous cell carcinoma

Gynecologic and Obstetric Investigation

Volumn 75, Issue 1, 2013, Pages 53-60

  De Melo Maia, Beatriz ^a   Munhoz Cestari, Flávia ^a   Lavorato Rocha, André Mourão ^a   Sant'ana Rodrigues, Iara ^a   Baiocchi, Glauco ^a   Cardoso Guimarães, Gustavo ^a   Vassallo, José ^a,c   Stiepcich, Mônica ^b   Soares, Fernando Augusto ^a   Malagoli Rocha, Rafael ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b Fleury   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Clinical pathology; Demographics; Surgery; Treatment; Vulvar cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; GRAFT NECROSIS; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; MARRIAGE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEROMA; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VULVA CARCINOMA; VULVECTOMY; WOUND COMPLICATION; WOUND INFECTION; BRAZILIAN; CANCER ADJUVANT THERAPY; CANCER MORTALITY; DYSURIA; MENARCHE; POSTOPERATIVE COMPLICATION; PRURITUS; SEXUAL INTERCOURSE; SURGICAL INFECTION; TUMOR INVASION; VAGINA BLEEDING; VAGINA PAIN; VAGINAL SECRETION; VAGINAL ULCER; VULVA SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CARCINOMA, SQUAMOUS CELL; EDUCATIONAL STATUS; FEMALE; HUMANS; INCIDENCE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VULVAR DISEASES; VULVAR NEOPLASMS; YOUNG ADULT;

EID: 84872612526     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000343758     Document Type: Article

References (35)

1. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics. CA Cancer J Clin 1998; 48: 6-29.
2. Creasman WT, Phillips JL, Menck HR: The National Cancer Data Base report on early stage invasive vulvar carcinoma: the American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1997; 80: 505-513.
3. Nogueira MC, Guedes Neto EP, Rosa MW, Zettler E, Zettler CG: Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva. Pathol Oncol Res 2006; 12: 3.
4. American Cancer Society: Cancer reference information, 2011. Retrieved August 1, 2012, from http://www.cancer.org.
5. Messing MJ, Gallup DG: Carcinoma of the vulva in young women. Obstet Gynecol 1995; 86: 51-54.
6. Joura EA, Losch A, Haider-Angeler MG, Breitenecker G, Leodolter S: Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 2000; 45: 613-615.
7. Lanneau GS, Argenta PA, Lanneau MS, Riffeburgh RH, Gold MA, McMeekin DS et al.: Vulvar cancer in young women: demographic features and outcome evaluation. Am J Obstet Gynecol 2009; 200: 645.
8. Woelber L, Mahner S, Voelker K, Eulenburg CZ, Gieseking F, Choschzick M, et al: Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res 2009; 29: 545-552.
9. Jones RW, Baranyai J, Stables S: Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol 1997; 90: 448-452.
10. National Cancer Institute (NCI): Cancer Facts and Figures, 2005. Washington. Retrieved August 1, 2012, from http://www. cancer.gov/cancertopics/ types/vulvar.
11. International Agency for Research on Cancer (WHO): International Association of Cancer Registries (IARC): Cancer Incidence in Five Continents, Lyon, Scientific Publications, 1992, vol V.I.
12. Ministério da Saúde (Brasil): Instituto Nacional do Câncer (INCA) - Câncer no Brasil: Dados dos registros de Base populacional. Retrieved August 1, 2011, from http://www. inca.gov.br/estimativa/ 2012/index.asp ?ID=5 [Portuguese].
13. de Hullu JA, van der Avoort IA, Oonk MH, van der Zee AG: Management of vulvar cancers. Eur J Surg Oncol 2006; 32: 825-831.
14. de Hullu JA, van der Zee AG: Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol 2006; 60: 38-58.
15. Dittmer C, Katalinic A, Mundhenke C, Thill M, Fischer D: Epidemiology of vulvar and vaginal cancer in Germany. Arch Gynecol Obstet 2011; 284: 169-174.
16. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA: Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 2006; 107: 1018-1022.
17. Hørding U, Junge J, Daugaard S, Lundvall F, Poulsen H, Bock JE: Vulvar squamosu cell carvinoma and papillomaviruses: indications for two different etiologies. Gynecol Oncol 1994; 52: 241-246.
18. Kumar S, Shah JP, Bryant CS, Imudia AN, Morris RT, Malone JM: A comparison of younger vs older women with vulvar cancer in the United States. Am J Obstet Gynecol 2009; 200: 52-55.
19. Maggard MA, O'Connell JB, Lane KE, Liu JH, Etzioni DA, Ko CY: Do young breast cancer patients have worse outcomes? J Surg Res 2003; 113: 109-113.
20. Pinto AP, Signorello LB, Crum CP, Harlow BL, Abrão F, Villa LL: Squamous cell carcinoma of the vulva in Brazil: prognostic importance of host and viral variables. Gynecol Oncol 1999; 74: 61-67.
21. Saraiya M, Watson M, Wu X, King JB, Chen VW, Smith JS, Giuliano AR: Incidence of in situ and invasive vulvar cancer in the US, 1998-2003. Cancer 2008; 15; 113: 2865-2872.
22. Watson M, Saraiya M, Wu X: Update of HPV-associated female genital cancers in the United States, 1999-2004. J Womens Health 2009; 18: 1731-1738.
23. Pena SD, Bastos-Rodrigues L, Pimenta JR, Bydlowski SP. DNA tests probe the genomic ancestry of Brazilians. Braz J Med Biol Res 2009; 10: 870-876.
24. Joura EA, Leodolter S, Hernandez-Avila M, et al: Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: A combined analysis of three randomised clinical trials. Lancet 2007; 369: 1693-1702.
25. Poppe W, Simon P, De Ridder M: Why consider human papillomavirus vaccination in older women? Gynecol Obstet Invest 2010; 70: 237-243.
26. Saraiya M, Rosser JI, Cooper CP: Cancers that US physicians believe the HPV vaccine prevents: findings from a physician survey, 2009. J Womens Health (Larchmt) 2012; 21: 111-117.
27. Villar LM, Rabello AD, de Paula VS: Evaluating knowledge about human papillomavirus infection among Brazilian health professionals. Asian Pac J Cancer Prev 2011; 12: 3251-3256.
28. Knopp S, Tropè C, Nesland JM, Holm R: A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice. J Clin Pathol 2009; 62: 212-218.
29. Coulter J, Gleason N: Local and regional recurrence of vulval cancer: management dilemmas. Best Pract Res Clin Obstet Gynaecol 2003; 17: 663-681.
30. Scheistrøen M, Nesland JM, Tropé C: Have patients with early squamous carcinoma of the vulva been overtreated in the past? The Norwegian experience 1977-1991. Eur J Gynaecol Oncol 2002; 23: 93-103.
31. Ghurani GB, Penalver MA: An update on vulvar cancer. Am J Obstet Gynecol 2001; 185: 294-299.
32. Maggino T, Landoni F, Sartori E, Zola P, Gadducci A, Alessi C, et al: Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer 2000; 89: 116-122.
33. Piura B, Masotina A, Murdoch J Lopes A, Morgan P, Monaghan J: Recurrent squamous cell carcinoma of the vulva: A study of 73 cases. Gynecol Oncol 1993; 48: 189-195.
34. Prempree T, Amornmarn R: Radiation treatment of recurrent carcinoma of the vulva. Cancer 1984; 54: 1943-1949.
35. Brandenberger AW, Rudlinger R, Hanggi W, et al: Detection of human papillomavirus in vulvar carcinoma. A study by in situ hybridisation. Arch Gynecol Obstet 1992; 252: 31-35.